RedHill Biopharma

RedHill Biopharma

RedHill Biopharma

RedHill Biopharma (NASDAQ/TASE: RDHL) is a biopharmaceutical company focused on development of late-stage drugs for inflammatory and gastrointestinal diseases
Founded
2009
Raised
$58.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$38,000,000
Post-IPO equity - 2016
$11,700,000
Post-IPO equity - 2014
Team Size
10+
Employees
Location
Headquarters
$38,000,000 Post-IPO equity
finanzen.at

RedHill BioPharma raises $38m in Nasdaq offering | 22.12.16